Effect of supplementation in treatment of gestational diabetes
Phase 3
- Conditions
- Gestational diabetes mellitus.Diabetes mellitus in pregnancy, unspecifiedO24.9
- Registration Number
- IRCT201506085623N43
- Lead Sponsor
- Kashan University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Pregnant women aged 18-40 years old diagnosed with GDM at 24-28 weeks' gestation
Exclusion Criteria
Patients with premature preterm rupture of membrane
Placenta abruption
Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Urinary tract infection
Smokers
Kidney or liver diseases
Required commencing insulin therapy during intervention
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting plasma glucose. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic.;Insulin. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Elisa.;Insulin resistance. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Calculation using HOMA formula.
- Secondary Outcome Measures
Name Time Method Triglycerides. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;HDL-cholesterol. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;Total cholesterol. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;VLDL. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;LDL. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.